InfraMed
Empowering post-stroke recovery with NIR.
THE PROBLEM
Reperfusion
without repair.
Ischemic stroke:
Tissue
Loss
Delayed
Protection
Ongoing
Damage
Limited
Recovery
Current ischemic stroke thrombectomy procedures successfully remove the occluding blood clot but do not address or restore the downstream tissue and cellular damage caused by prolonged ischemia.
OUR APPROACH
Beyond
clot removal.
Our approach uses near-infrared (NIR) light therapy to target ischemic brain tissue and stimulate cellular repair pathways that are not addressed by clot removal alone.
By enhancing mitochondrial function, we aim to support recovery and restore function in damaged regions beyond reperfusion.
Meet Our Team.
Jamie Salazar
Team Lead
Regulatory &
Compliance
Jocelyn Lin
Biological
Validation
Engineer
Kayleigh Sim
Biological
Validation
Engineer
Ethan Linares
Optics Engineer
Dean Zepeda
Optics Engineer
Zarnigor Sodikova
Simulation
Engineer
MARKET STRATEGY
Built for stroke
workflow.
Our market strategy focuses on integrating the device into the already existing mechanical thrombectomy workflow, allowing stroke centers to adopt the technology without major changes to already existing procedures or infrastructure.
We target a rapidly growing stroke therapeutics market projected to exceed $36B by 2031. Initial efforts will prioritize partnerships with comprehensive stroke centers, neurointerventional physicians, and catheter distributors to establish clinical validation and early adoption.
COMPETITOR ANALYSIS
Designed Beyond
Reperfusion.
Current Standard of Care
Thrombectomy
- Removes clot
- Restores blood flow
- No direct neuroprotection
- Standalone procedure
Previous PBM Approaches
Transcranial NIR
- Non-invasive delivery
- Poor tissue penetration
- Inconsistent energy delivery
- Failed large-scale efficacy trials
NTX Therapeutics
Localized Intravascular PBM
- Delivers light directly to target tissue
- Supports mitochondrial recovery
- Integrates into thrombectomy workflow
- Combines reperfusion + protection
| Thrombectomy | Traditional PBM | NTX Therapeutics | |
|---|---|---|---|
| Removes Occlusion | ✓ | × | ✓ |
| Neuroprotection | × | Limited | ✓ |
| Localized Delivery | × | × | ✓ |
| Workflow Integration | ✓ | × | ✓ |
VIDEO PITCH/DEMO